â Home
Medtronic 
Healthcare & biotech / Medical devices and services
Press Releases
| Date | Press release |
|---|---|
| 2025-04-30 11:24:00 | Smart Pills Market Industry Trend Analysis, And Forecast 2025-2034, With Profiles Of Anx Robotica, Bodycap, Capsovision, Check-cap, Etectrx, Intromedic, Medtronic, Otsuka, Olympus And Rf Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. smart pills, equipped with sensors and ai, facilitate real-time monitoring and personalized medicine. north america leads with usd 455.5 million in 2024. the market benefits from tech advancements, an aging population, and robust healthcare infrastructure, paving the way for continuous growth. key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. smart pills, equipped with sensors and ai, facilitate real-time monitoring and personalized medicine. north america leads with usd 455.5 million in 2024. the market benefits from tech advancements, an aging population, and robust healthcare infrastructure, paving the way for continuous growth. |
| 2025-04-26 19:20:00 | Medtronic Affera⢠Pulsed Field Ablation Technologies Continue To Demonstrate Promising Evidence For Atrial Fibrillation Patients One-year clinical trial data for the next-generation, investigational, sphere-360⢠single-shot pfa catheter show impressive safety, performance, and efficiency results for paroxysmal afib dual-energy (rf/pf), focal sphere-9⢠catheter demonstrates efficacy for linear ablation in persistent afib medtronic continues legacy of leadership in innovation, showcasing arrhythmia management portfolio at heart rhythm society annual meeting galway, ireland and san diego , april 26, 2025 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation (afib) patients treated with the affera⢠family of technologies, including the next-generation sphere-360⢠single-shot pulsed field ablation (pfa) catheter and the groundbreaking sphere-9⢠combination mapping and dual-energy focal pfa catheter. data were presented in high impact science sessions at the heart rhythm society 2025 annual meeting in san diego; the sphere-360 study was simultaneously published in the heart rhythm journal. |
| 2025-04-26 14:20:00 | Medtronic Expand Uro U.s. Clinical Trial Meets Safety And Effectiveness Primary Endpoints For Hugo⢠Robotic-assisted Surgery System Largest multi-center prospective investigational device exemption (ide) study for multi-port robotic-assisted urologic surgery in the u.s. presented as a late-breaker at the american urologic association annual meeting company confirms hugo ras system submission to the u.s. food and drug administration galway, ireland and las vegas , april 26, 2025 /prnewswire/ -- medtronic (nyse: mdt), a global leader in healthcare technology, today announced that the expand uro investigational device exemption (ide) clinical study, the largest such study for robotic-assisted urologic surgery ever conducted, met both primary safety and effectiveness endpoints. the prospective, multi-center, single-arm ide study included 137 patients who underwent urologic procedures using the hugo⢠robotic-assisted surgery (ras) system. |
| 2025-04-25 17:45:00 | Medtronic Receives Fda Approval For Smallest-diameter, Lumenless Defibrillation Lead, The Omniasecure⢠Lead And Announces Investigational Clinical Study Results Adding to the medtronic portfolio of catheter-based lead solutions, the novel omniasecure defibrillation lead allows for precise delivery and placement in the right ventricle heart rhythm 2025: late-breaking clinical study results evaluating the omniasecure lead for investigational use in the lbbap location show high defibrillation success galway, ireland and san diego , april 25, 2025 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, received u.s. food and drug administration (fda) approval for the omniasecure⢠defibrillation lead for placement within the right ventricle. the lead, built on the highly reliable selectsecure⢠model 3830 pacing lead and delivered via catheter, builds on the medtronic portfolio of lead solutions designed for precise delivery and placement. |
| 2025-04-24 09:00:00 | Medtronic Advances Abbott Cgm Partnership With Fda Submission Of Interoperable Insulin Pump Galway, ireland , april 24, 2025 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the u.s. food and drug administration (fda) seeking clearance for an interoperable pump. fda clearance of this pump would pave the way for system integration with a continuous glucose monitoring (cgm) sensor based on abbottâs most advanced cgm platform. |
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Legal